Atlantic Coastal Acquisition Corp. II Files 8-K
Ticker: ABPWW · Form: 8-K · Filed: Aug 28, 2024 · CIK: 1893219
| Field | Detail |
|---|---|
| Company | Atlantic Coastal Acquisition CORP. II (ABPWW) |
| Form Type | 8-K |
| Filed Date | Aug 28, 2024 |
| Risk Level | medium |
| Pages | 9 |
| Reading Time | 10 min |
| Key Dollar Amounts | $0.0001, $11.50, $10.00, $6,224,670, $30 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, equity-sale, filing
TL;DR
ACII filed an 8-K on Aug 22, 2024, for material definitive agreement & unregistered equity sales.
AI Summary
Atlantic Coastal Acquisition Corp. II (ACII) entered into a Material Definitive Agreement on August 22, 2024, related to unregistered sales of equity securities. The filing also includes financial statements and exhibits, with the company's fiscal year ending on December 31st.
Why It Matters
This 8-K filing indicates a significant corporate action or event, potentially impacting the company's stock and future business operations.
Risk Assessment
Risk Level: medium — 8-K filings can signal significant events, but without details on the agreement, the specific risk is unclear.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
Key Players & Entities
- Atlantic Coastal Acquisition Corp. II (company) — Registrant
- August 22, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-41224 (identifier) — SEC File Number
FAQ
What is the nature of the Material Definitive Agreement filed on August 22, 2024?
The filing indicates a Material Definitive Agreement was entered into on August 22, 2024, but the specific details of the agreement are not provided in the summary information.
What type of equity securities were sold under the unregistered sales provision?
The filing mentions 'Unregistered Sales of Equity Securities' and also refers to 'Units, each consisting of one share of Series A common stock... and one-half of one redeemable warrant', suggesting these were the securities involved.
What is the SIC code for Atlantic Coastal Acquisition Corp. II?
The Standard Industrial Classification (SIC) code for Atlantic Coastal Acquisition Corp. II is 2836, which corresponds to BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
When is Atlantic Coastal Acquisition Corp. II's fiscal year end?
Atlantic Coastal Acquisition Corp. II's fiscal year ends on December 31st.
What is the primary purpose of this 8-K filing?
This 8-K filing serves to report the entry into a Material Definitive Agreement, unregistered sales of equity securities, and includes Regulation FD Disclosure and Financial Statements and Exhibits.
Filing Stats: 2,560 words · 10 min read · ~9 pages · Grade level 15.3 · Accepted 2024-08-28 16:01:56
Key Financial Figures
- $0.0001 — of one share of Series A common stock, $0.0001 par value, and one-half of one redeemab
- $11.50 — A common stock at an exercise price of $11.50 ACABW The Nasdaq Stock Market LLC
- $10.00 — osing (as defined below), at a price of $10.00 per share, for an aggregate purchase pr
- $6,224,670 — are, for an aggregate purchase price of $6,224,670. In addition, Abpro Bio will be granted
- $30 million — 20 and, in connection therewith, made a $30 million equity investment in the Company. Addit
- $6 million — the aggregate principal amount of up to $6 million for the benefit of Abpro Bio Internatio
- $4,224,663.33 — for the Abpro Bio PIPE Shares includes $4,224,663.33 under the Company Loan that shall be fo
- $5,000,000 — are, for an aggregate purchase price of $5,000,000. In addition, Celltrion will be granted
Filing Documents
- d889794d8k.htm (8-K) — 44KB
- d889794dex101.htm (EX-10.1) — 118KB
- d889794dex102.htm (EX-10.2) — 24KB
- 0001193125-24-208786.txt ( ) — 394KB
- acab-20240822.xsd (EX-101.SCH) — 3KB
- acab-20240822_def.xml (EX-101.DEF) — 14KB
- acab-20240822_lab.xml (EX-101.LAB) — 23KB
- acab-20240822_pre.xml (EX-101.PRE) — 15KB
- d889794d8k_htm.xml (XML) — 7KB
Forward-Looking Statements
Forward-Looking Statements This Current Report on Form 8-K includes certain statements that are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as "believe", "project", "expect", "anticipate", "estimate", "intend", "strategy", "future", "opportunity", "plan", "may", "should", "will", "would", "will be", "will continue", "will likely result" or similar expressions. that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of revenue and other financial and performance metrics and projections of market opportunity and expectations, ACAB's ability to enter into definitive agreements or consummate a transaction with the Company; ACAB's ability to obtain the financing necessary consummate the Proposed Transactions; and the expected timing of completion of the Proposed Transactions. These statements are based on various assumptions and on the current expectations of ACAB's and the Company's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of ACAB and the Company. These forward looking statements are subject to a number of risks and uncertainties, including general economic, financial, legal, political and business conditions and changes in domestic and foreign markets; the outcome of judicial proceedings to which the Com